FDA Inspection 925090 — Batzofin Fertility Services d.b.a. New York Fertility Services

Batzofin Fertility Services d.b.a. New York Fertility Services — FEI 3007196536

The FDA completed an inspection of Batzofin Fertility Services d.b.a. New York Fertility Services on May 6, 2015 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 6, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)